Low Ototoxicity Rates in Children with Medulloblastoma Treated with Proton Therapy
Author Information
Author(s): Moeller Benjamin J, Chintagumpala Murali, Philip Jimmy J, Grosshans David R, McAleer Mary F, Woo Shiao Y, Gidley Paul W, Vats Tribhawan S, Mahajan Anita
Primary Institution: University of Texas M.D. Anderson Cancer Center
Hypothesis
Does proton radiotherapy reduce early ototoxicity in pediatric medulloblastoma patients compared to traditional methods?
Conclusion
Proton radiotherapy results in low rates of high-grade early post-radiation ototoxicity for pediatric medulloblastoma patients.
Supporting Evidence
- The mean cochlear radiation dose was 30 CGE, with a favorable high-grade ototoxicity rate of 5%.
- Hearing sensitivity significantly declined following radiotherapy across all frequencies analyzed.
- Ototoxicity did not correlate with predicted dose to the auditory apparatus for proton-treated patients.
Takeaway
Kids with brain tumors who get special proton therapy have less chance of losing their hearing compared to other treatments.
Methodology
The study involved 23 children treated with proton radiotherapy, with audiometric testing conducted before and one year after treatment.
Potential Biases
Comparisons with other treatment modalities may be subject to bias due to differences in treatment protocols.
Limitations
The study had a small sample size and lacked long-term follow-up.
Participant Demographics
Participants were children aged 3 to 16, with a majority being male (74%).
Statistical Information
P-Value
<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website